Cargando…
Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib
| Autores principales: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024068/ https://www.ncbi.nlm.nih.gov/pubmed/35459222 http://dx.doi.org/10.1038/s41408-022-00651-3 |
| _version_ | 1784690485142487040 |
|---|---|
| author | Harrington, Patrick Doores, Katie J. Saunders, Jamie de Lord, Marc Saha, Chandan Lechmere, Thomas Khan, Hataf Lam, Ho Pui Jeff Reilly, Amy O’ Woodley, Claire Asirvatham, Susan Dillon, Richard Curto-Garcia, Natalia Sullivan, Jennifer O’ Kordasti, Shahram Raj, Kavita Malim, Michael H. Radia, Deepti McLornan, Donal Harrison, Claire de Lavallade, Hugues |
| author_facet | Harrington, Patrick Doores, Katie J. Saunders, Jamie de Lord, Marc Saha, Chandan Lechmere, Thomas Khan, Hataf Lam, Ho Pui Jeff Reilly, Amy O’ Woodley, Claire Asirvatham, Susan Dillon, Richard Curto-Garcia, Natalia Sullivan, Jennifer O’ Kordasti, Shahram Raj, Kavita Malim, Michael H. Radia, Deepti McLornan, Donal Harrison, Claire de Lavallade, Hugues |
| author_sort | Harrington, Patrick |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9024068 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90240682022-04-22 Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib Harrington, Patrick Doores, Katie J. Saunders, Jamie de Lord, Marc Saha, Chandan Lechmere, Thomas Khan, Hataf Lam, Ho Pui Jeff Reilly, Amy O’ Woodley, Claire Asirvatham, Susan Dillon, Richard Curto-Garcia, Natalia Sullivan, Jennifer O’ Kordasti, Shahram Raj, Kavita Malim, Michael H. Radia, Deepti McLornan, Donal Harrison, Claire de Lavallade, Hugues Blood Cancer J Correspondence Nature Publishing Group UK 2022-04-22 /pmc/articles/PMC9024068/ /pubmed/35459222 http://dx.doi.org/10.1038/s41408-022-00651-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Harrington, Patrick Doores, Katie J. Saunders, Jamie de Lord, Marc Saha, Chandan Lechmere, Thomas Khan, Hataf Lam, Ho Pui Jeff Reilly, Amy O’ Woodley, Claire Asirvatham, Susan Dillon, Richard Curto-Garcia, Natalia Sullivan, Jennifer O’ Kordasti, Shahram Raj, Kavita Malim, Michael H. Radia, Deepti McLornan, Donal Harrison, Claire de Lavallade, Hugues Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib |
| title | Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib |
| title_full | Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib |
| title_fullStr | Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib |
| title_full_unstemmed | Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib |
| title_short | Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib |
| title_sort | impaired humoral and t cell response to vaccination against sars-cov-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024068/ https://www.ncbi.nlm.nih.gov/pubmed/35459222 http://dx.doi.org/10.1038/s41408-022-00651-3 |
| work_keys_str_mv | AT harringtonpatrick impairedhumoralandtcellresponsetovaccinationagainstsarscov2inchronicmyeloproliferativeneoplasmpatientstreatedwithruxolitinib AT dooreskatiej impairedhumoralandtcellresponsetovaccinationagainstsarscov2inchronicmyeloproliferativeneoplasmpatientstreatedwithruxolitinib AT saundersjamie impairedhumoralandtcellresponsetovaccinationagainstsarscov2inchronicmyeloproliferativeneoplasmpatientstreatedwithruxolitinib AT delordmarc impairedhumoralandtcellresponsetovaccinationagainstsarscov2inchronicmyeloproliferativeneoplasmpatientstreatedwithruxolitinib AT sahachandan impairedhumoralandtcellresponsetovaccinationagainstsarscov2inchronicmyeloproliferativeneoplasmpatientstreatedwithruxolitinib AT lechmerethomas impairedhumoralandtcellresponsetovaccinationagainstsarscov2inchronicmyeloproliferativeneoplasmpatientstreatedwithruxolitinib AT khanhataf impairedhumoralandtcellresponsetovaccinationagainstsarscov2inchronicmyeloproliferativeneoplasmpatientstreatedwithruxolitinib AT lamhopuijeff impairedhumoralandtcellresponsetovaccinationagainstsarscov2inchronicmyeloproliferativeneoplasmpatientstreatedwithruxolitinib AT reillyamyo impairedhumoralandtcellresponsetovaccinationagainstsarscov2inchronicmyeloproliferativeneoplasmpatientstreatedwithruxolitinib AT woodleyclaire impairedhumoralandtcellresponsetovaccinationagainstsarscov2inchronicmyeloproliferativeneoplasmpatientstreatedwithruxolitinib AT asirvathamsusan impairedhumoralandtcellresponsetovaccinationagainstsarscov2inchronicmyeloproliferativeneoplasmpatientstreatedwithruxolitinib AT dillonrichard impairedhumoralandtcellresponsetovaccinationagainstsarscov2inchronicmyeloproliferativeneoplasmpatientstreatedwithruxolitinib AT curtogarcianatalia impairedhumoralandtcellresponsetovaccinationagainstsarscov2inchronicmyeloproliferativeneoplasmpatientstreatedwithruxolitinib AT sullivanjennifero impairedhumoralandtcellresponsetovaccinationagainstsarscov2inchronicmyeloproliferativeneoplasmpatientstreatedwithruxolitinib AT kordastishahram impairedhumoralandtcellresponsetovaccinationagainstsarscov2inchronicmyeloproliferativeneoplasmpatientstreatedwithruxolitinib AT rajkavita impairedhumoralandtcellresponsetovaccinationagainstsarscov2inchronicmyeloproliferativeneoplasmpatientstreatedwithruxolitinib AT malimmichaelh impairedhumoralandtcellresponsetovaccinationagainstsarscov2inchronicmyeloproliferativeneoplasmpatientstreatedwithruxolitinib AT radiadeepti impairedhumoralandtcellresponsetovaccinationagainstsarscov2inchronicmyeloproliferativeneoplasmpatientstreatedwithruxolitinib AT mclornandonal impairedhumoralandtcellresponsetovaccinationagainstsarscov2inchronicmyeloproliferativeneoplasmpatientstreatedwithruxolitinib AT harrisonclaire impairedhumoralandtcellresponsetovaccinationagainstsarscov2inchronicmyeloproliferativeneoplasmpatientstreatedwithruxolitinib AT delavalladehugues impairedhumoralandtcellresponsetovaccinationagainstsarscov2inchronicmyeloproliferativeneoplasmpatientstreatedwithruxolitinib |